William Hoffman - 01 May 2024 Form 4 Insider Report for Inari Medical, Inc.

Role: Director
Signature: /s/ Shannon Trevino, attorney-in-fact for William Hoffman
Issuer symbol: N/A
Transactions as of: 01 May 2024
Net transactions value: -$1,619,047
Form type: 4
Filing time: 03 May 2024, 17:40:43 UTC
Previous filing: 26 Apr 2024
Next filing: 17 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Sale	$1,503,885	-35,858	-3.6%	$41.94	968,050	01 May 2024	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$106,440	-2,491	-0.26%	$42.73	965,559	01 May 2024	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$8,722	-200	-0.02%	$43.61	965,359	01 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.
F2	This transaction was executed in multiple trades at prices ranging from $41.25 to $42.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $42.50 to $43.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.